Wondering how long does it take for CGRP medication to work? Learn the typical timeline, what to track each month, and when to talk to your neurologist.
One of the most common questions after starting a CGRP preventive is how long does it take for CGRP medication to work. The honest answer is that it varies by person, but there is a well-established typical window that clinicians use to evaluate response. Understanding that window, and what to watch for inside it, is what this article covers.
CGRP (calcitonin gene-related peptide) is a protein involved in migraine pain signaling. Preventive medications that target CGRP or its receptor work by reducing the availability of that signal over time. This is a physiological change, not an immediate block, so the effect builds gradually as the body adjusts.
Think of it like blood pressure medication: you do not feel your blood pressure normalize in a single day. The medication accumulates in the system, receptor binding patterns shift, and the downstream effect on migraine threshold becomes apparent over weeks to months. Setting realistic expectations from the start makes it easier to stay the course and collect the data your clinician needs.
The table below reflects the general clinical pattern described across headache medicine guidelines. Individual experiences will differ, and only your clinician can interpret your specific response.
| Timepoint | What Often Happens | What to Track |
|---|---|---|
| Month 1 | Frequency may drop slightly or remain unchanged. Side effects, if any, are most likely to appear early. | Daily migraine days, severity ratings, any new symptoms to report |
| Month 2 | Many people begin to notice a meaningful reduction in attack frequency or severity. Patterns become clearer. | Monthly migraine day count, acute medication use, HIT-6 or MIDAS score |
| Month 3 | The standard evaluation window. A full three-month picture provides enough data for a clinician to assess response and make evidence-based decisions. | Three-month average migraine days vs. baseline, disability score trend |
| Month 4 and beyond | For some people, benefit continues to increase gradually. Insurers often require documentation of continued response at renewal. | Ongoing monthly counts, year-over-year comparisons for renewal |
The three-month mark is not arbitrary. It reflects the time needed to separate treatment effect from natural month-to-month variability in migraine frequency, which can be substantial even without any intervention.
A 50 percent or greater reduction in monthly migraine days from your pre-treatment baseline is the threshold most commonly used in clinical trials and by insurers evaluating prior authorization renewals. But that single number does not capture the full picture.
A meaningful response may also include:
You can learn more about how those scores are calculated and interpreted at MIDAS and HIT-6 explained. Tracking all of these dimensions, not just migraine day count, gives you and your clinician a complete picture of whether treatment is actually reducing your burden.
The most common mistake people make is starting a CGRP preventive without a solid pre-treatment baseline. If you do not know how many migraine days you were averaging before you started, you cannot objectively measure whether the number has changed.
A baseline is not optional. It is the denominator in every calculation your clinician and insurer will use to evaluate your response.
Ideally, you track for at least two to three months before starting a new preventive, or use documented records from prior appointments as a proxy. Once you begin the medication, consistent daily logging turns three months of data into the kind of concrete report that supports both clinical decisions and insurance renewals.
See how to track migraines accurately for a practical guide on what to log each day and how to avoid the common pitfalls that skew the data.
If you are in month one or two and wondering whether anything is happening, here are signs that suggest you are on a reasonable trajectory:
None of these individually confirm that the treatment is working, but together they suggest a trend worth continuing to monitor. The migraine reduction calculator lets you enter your baseline and current monthly counts to see your percentage reduction in real time.
If your monthly migraine days, disability scores, and acute medication use are all unchanged after a full three-month trial, that is objective information, not a personal failure. Bring your tracked data to your neurologist or headache specialist and ask for a formal treatment review.
Options your clinician may consider include adjusting the dosing schedule, switching to a different CGRP-targeting mechanism, or adding another preventive approach. Only your prescriber can evaluate those options and recommend next steps based on your full medical history.
For a detailed walkthrough of the metrics to review at that appointment, see measuring CGRP progress.
Month-to-month variability in migraine frequency is real and can mislead you in either direction. A single unusually good month may reflect treatment benefit, or it may reflect lower stress, favorable weather, or hormonal timing. A single bad month does not mean the medication stopped working.
This is why monthly migraine days should be averaged across the full three-month evaluation window before drawing conclusions. Compare your three-month average on treatment to your three-month pre-treatment baseline. That comparison is far more reliable than any individual month.
You can also use the HIT-6 calculator to track your headache impact score each month alongside your migraine day count. The combination of frequency data and disability data is more persuasive to both clinicians and insurers than frequency alone.
Consistent tracking across the three-month window turns this general knowledge into a specific, timestamped record tied to your name and your prescription. When renewal time arrives, that logged history becomes the documentation your clinician needs to write a persuasive prior authorization letter and that your insurer needs to approve continued coverage. The app captures all of it automatically as you go. As always, talk to your doctor before starting, stopping, or changing any treatment.
Educational, not medical advice. Migraine Tracker: CGRP Log is a personal tracking tool, not a medical device. It does not diagnose, treat, or provide medical advice. Always talk to your clinician.
Most people see meaningful improvement within two to three months, though some notice a reduction in attack frequency as early as the first month. Clinicians typically evaluate response after a full three-month trial at an adequate dose before considering any changes.
CGRP migraine prevention what to expect, month by month: timelines, side effects, tracking, and the questions to bring to your clinician.
Learn how CGRP first line migraine prevention guidelines are shifting, what this means for patients, and what to track to support your treatment decisions.
Understand what to do if CGRP medication doesn't work, why partial or no response happens, and what questions to bring to your neurologist.
